Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00051532
Status:
TERMINATED
Last Update Posted:
2007-03-06
First Post:
2003-01-13
Brief Title:
Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
Sponsor:
LEO Pharma
Organization:
LEO Pharma
Study Overview
Official Title:
Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma Efficacy of Seocalcitol EB 1089 Enteric-Coated Capsules 5ug or Placebo in the Treatment of Patients With Hepatocellular Carcinoma Not Amenable to Curative Treatment
Status:
TERMINATED
Status Verified Date:
2005-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine whether seocalcitol is effective in the treatment of advanced primary liver cancer hepatocellular carcinoma HCC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EBC 9801 INT | None | None | None |